CJC 1295 (No DAC) + Ipamorelin Synergistic GH Releasing Peptide Duo Ipamorelin CJC 1295 PRAMAH THE HAVEN What are the considerations and potential risks for using Ipamorelin (growth hormone secretagogue) in women, particularly those with a history of cancer, diabetes, or other underlying medical conditions? Some peptides can be risky if someone has active or recent cancer. Peptides that raise growth hormone or IGF 1, like IGF 1 LR3, IGF 1 DES, Tesamorelin, Sermorelin, CJC 1295, and Ipamorelin, increase growth signals